OSE Immunotherapeutics SA
F:6OP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
OSE Immunotherapeutics SA
F:6OP
|
FR |
|
H
|
Home Depot Inc
XMUN:HDI
|
US |
|
Clover Health Investments Corp
NASDAQ:CLOV
|
US |
|
Innate Pharma SA
PAR:IPH
|
FR |
|
M
|
Manulife Financial Corp
F:MLU
|
CA |
|
C
|
Ceres Power Holdings PLC
F:CFJ
|
UK |
|
C
|
China Telecom Corp Ltd
XMUN:ZCH
|
CN |
|
Pharnext SA
PAR:ALPHA
|
FR |
|
Xiaomi Corp
F:3CP
|
CN |
|
Y
|
Ypsomed Holding AG
XBER:OWX
|
CH |
|
AT & S Austria Technologie & Systemtechnik AG
F:AUS
|
AT |
Shareholder Yield
Current shareholder yield for 
6OP is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
6OP Price
OSE Immunotherapeutics SA
| Average Annual Return | -2.74% |
| Standard Deviation of Annual Returns | 49.9% |
| Max Drawdown | -80% |
| Market Capitalization | 68.4m EUR |
| Shares Outstanding | 21 778 000 |
| Percentage of Shares Shorted |
N/A
|
